A detailed history of Sugarloaf Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sugarloaf Wealth Management, LLC holds 1,220 shares of AZN stock, worth $78,616. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,220
Previous 1,138 7.21%
Holding current value
$78,616
Previous $88,000 7.95%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$76.67 - $87.62 $6,286 - $7,184
82 Added 7.21%
1,220 $95,000
Q4 2023

Jan 10, 2024

SELL
$61.89 - $69.28 $7,674 - $8,590
-124 Reduced 9.83%
1,138 $76,000
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $64 - $71
1 Added 0.08%
1,262 $85,000
Q2 2023

Jul 13, 2023

SELL
$69.91 - $75.81 $7,270 - $7,884
-104 Reduced 7.62%
1,261 $90,000
Q1 2023

Apr 26, 2023

BUY
$63.15 - $71.6 $63 - $71
1 Added 0.07%
1,365 $94,000
Q4 2022

Feb 03, 2023

BUY
$54.21 - $70.44 $5,637 - $7,325
104 Added 8.25%
1,364 $92,000
Q3 2022

Oct 11, 2022

BUY
$53.02 - $135.75 $53 - $135
1 Added 0.08%
1,260 $70,000
Q2 2022

Jul 12, 2022

BUY
$59.26 - $71.14 $4,266 - $5,122
72 Added 6.07%
1,259 $83,000
Q1 2022

Apr 25, 2022

BUY
$55.72 - $67.12 $111 - $134
2 Added 0.17%
1,187 $79,000
Q3 2021

Oct 20, 2021

BUY
$55.56 - $60.79 $2,833 - $3,100
51 Added 4.5%
1,185 $71,000
Q1 2021

Apr 19, 2021

SELL
$47.16 - $54.44 $848 - $979
-18 Reduced 1.56%
1,134 $56,000
Q4 2020

Feb 03, 2021

SELL
$48.52 - $58.02 $31,149 - $37,248
-642 Reduced 35.79%
1,152 $58,000
Q3 2020

Nov 03, 2020

SELL
$53.07 - $61.1 $22,873 - $26,334
-431 Reduced 19.37%
1,794 $98,000
Q2 2020

Jul 21, 2020

BUY
$43.1 - $55.31 $1,034 - $1,327
24 Added 1.09%
2,225 $118,000
Q4 2019

Jan 29, 2020

BUY
$42.46 - $50.46 $93,454 - $111,062
2,201 New
2,201 $110,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Sugarloaf Wealth Management, LLC Portfolio

Follow Sugarloaf Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.